The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...

Renibus has completed subject enrolment for the Phase III PROTECT trial of RBT-1 in minimising post-operative risk in cardiac ...

Clinical ink has launched the AI-powered, fully integrated analytics dashboard, TrialLens, which is designed to interpret ...

At ESCMID 2025, early data suggest that Assembly Biosciences’ ABI-5366 could redefine the treatment landscape for recurrent genital herpes (RGH).

Tiziana Life Sciences has announced the commencement of dosing in the fourth clinical site of the company’s Phase II trial of ...

Lokavant has launched the AI-powered clinical trial forecasting solution, Spectrum v15, to dispel uncertainty in the ...

After a number of Phase III successes in China, Summit is launching a multi-regional trial as the race for approval in the US and elsewhere across the globe begins. Image credit: Shutterstock / Tuhaa ...

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved since the 1990s.

According to the WHO, meningitis is a significant global health threat even though treatments and vaccines against some forms are available.

Contraception for women has seen little change over the past 50 years, with the most prevalent contraceptive pills containing ...

The US FDA has cleared the IND application of Aclaris to commence the placebo-controlled Phase Ia/Ib study of the ATI-052 ...

BMS has reported topline outcomes from the ARISE trial of Cobenfy as an adjunctive treatment to atypical antipsychotics for schizophrenia.